Genesis Pharmaceuticals Enterprises, Inc. (OTC BB: GTEC)

Genesis Pharmaceuticals Enterprises, Inc. (OTC BB: GTEC) is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People’s Republic of China. Genesis is a major pharmaceutical company in China producing tablets, capsules, and granules for both western and Chinese herbal- based medical drugs. The company has recently appointed Michael Marks to its Board of Directors and is looking to capitalize on the international pharmaceutical market.